Verteporfin and Intravitreal Triamcinolone Acetonide Combination Therapy for Occult Choroidal Neovascularization in Age-Related Macular Degeneration

This publication has 30 references indexed in Scilit:

• Safety of an Intravitreal Injection of Triamcinolone
  Archives of Ophthalmology (1950), 2004
• Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration
  British Journal of Ophthalmology, 2004
• VERTEPORFIN THERAPY OF SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION
  Retina, 2004
• Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1
  American Journal of Ophthalmology, 2003
• Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization
  Ophthalmology, 2003
• A Randomized Clinical Trial of a Single Dose of Intravitreal Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration
  Archives of Ophthalmology (1950), 2003
• Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
  American Journal of Ophthalmology, 2001
• INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
  Retina, 2000
• Intravitreal triamcinolone and elevated intraocular pressure
  Australian and New Zealand Journal of Ophthalmology, 1999
• Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin
  Archives of Ophthalmology (1950), 1999